Showing results (711-720 of 14,087) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|January 1, 1989
Randomized phase III trial of chemoimmunotherapy in patients with previously untreated stage III, optimal disease ovarian cancer: a Southwest Oncology Group StudyD S Alberts, N Mason-Liddil, R V O'Toole, et al.Gynecologic Oncology|January 1, 1989
Pelvic fibromatosis: case report and review of literatureA Manetta, A B Abt, A C Mamourian, et al.Gynecologic Oncology|December 25, 2015
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trialKenji Umayahara, Munetaka Takekuma, Yasuyuki Hirashima, et al.Gynecologic Oncology|December 27, 2015
Novel technique for the complete staging of endometrial cancer by single-port laparoscopyIgnacio Zapardiel, Estefanía Moreno, Antonio Piñera, et al.Gynecologic Oncology|January 26, 2016
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabaseJacek P Grabowski, Philipp Harter, Florian Heitz, et al.Gynecologic Oncology|November 21, 2015
Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based studyY K Eysbouts, J Bulten, P B Ottevanger, et al.Gynecologic Oncology|January 16, 2016
Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signaturesYeheli Ravid, Malka Formanski, Yoav Smith, et al.Gynecologic Oncology|January 6, 2016
Prognostic significance of highly sulfated chondroitin sulfates in ovarian cancer defined by the single chain antibody GD3A11Sophieke C H A van der Steen, Angela A G van Tilborg, Myrtille J E Vallen, et al.Gynecologic Oncology|January 6, 2016
The importance of para-aortic lymph nodes in sentinel lymph node mapping for endometrial cancer by using hysteroscopic radio-isotope tracer injection combined with subserosal dye injection: Prospective studyFumio Kataoka, Nobuyuki Susumu, Wataru Yamagami, et al.Gynecologic Oncology|January 24, 2016
Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMICaroline C Billingsley, Catherine Cansino, David M O'Malley, et al.Pageof 1,409